Stock search

Ticker or company name

Compare stocks

Market: US

  • SYKStryker Corporation
  • CVSCVS Health
  • MCKMcKesson

Add stock

Ticker or company

Summary

SYK
Stryker Corporation
$310,72Up +0,35%
Year: Down −17%
72/100Ratio would consider buying
Open stock page
CVS
CVS Health
$88,59Down −0,85%
Year: Up +13%
83/100Best scoreRatio would consider buying
Open stock page
MCK
McKesson
$1 105,04Up +0,20%
Year: Up +30%
72/100Ratio would consider buying
Open stock page

Verdict

CVS has the best score (83). MCK grows revenue the fastest. CVS is the cheapest by forward P/E. CVS has the lowest debt load. SYK has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckSYK5 ✓ 3 — 1 ✕CVS6 ✓ 3 — 0 ✕MCK5 ✓ 3 — 1 ✕
P/E vs its history33,010,427,3
P/E vs industry33,010,427,3
Forward P/E18,210,720,7
Revenue growth, YoY+7,9%+6,7%+8,2%
EPS growth, YoY+23,4%+2 107,7%+21,2%
Net margin13,8%2,6%1,1%
Net debt / EBITDA1,8−0,80,4
Free cash flow$4,57 bn$15,6 bn$7,11 bn
Share count over a year−0,5%+1,7%−6,2%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterSYKTTMCVSTTMMCKTTMIndustry medianTTM
P/E TTM ↓Worst: 33,0Best: 10,427,325,1
Forward P/E ↓18,2Best: 10,7Worst: 20,716,2
PEG ↓Worst: 3,1Best: 1,82,22,2
P/S TTM ↓Worst: 4,5Best: 0,30,32,2
EV/EBITDA ↓Worst: 21,5Best: 10,818,817,3
P/FCF ↓Worst: 26,1Best: 7,317,719,5

Price, %

  • SYKn/a
  • CVSn/a
  • MCKn/a

Returns

Best WorstNo mark — in between

PeriodSYKCVSMCK
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

SYKCVSMCK
Share of “buy”Worst: 77%Best: 88%82%
Beat the forecastWorst: 2 of 4Best: 4 of 4Best: 4 of 4
Average “surprise”Worst: −2,5%Best: +22,0%+2,9%
Insiders over 12 monthssales $580 msales $322 msales $29,3 m

Details are on each stock page.